If you've been using Zyrtec or Xyzal to combat your allergy symptoms this year, an FDA warning wants you to be aware of this ...

“Reported cases were rare but sometimes serious, with patients experiencing widespread, severe itching that required medical ...

Investigating allergy prevention, this research highlights early intervention strategies and the promise of biologic ...

Although the side effect is rare, the FDA said some patients experienced severe itching that required medical attention.

Some patients may suffer from unbearable itching across their entire body after stopping common allergy medications, health ...

Japan’s Intellectual Property High Court has ordered Sawai Pharmaceutical (TYO: 4887) and Fuso Pharmaceutical Industries (TYO ...

The patient’s medical history was significant for mild atopic dermatitis, well-controlled with triamcinolone ointment used ...

Rilzabrutinib is a promising treatment option for patients with chronic spontaneous urticaria who are refractory to antihistamines.

Two antihistamines, including Zyrtec, are under warning by the FDA after people reported “severe itching” after ceasing ...

Panelists discuss how ruxolitinib provides comprehensive benefits for polycythemia vera patients beyond count control, highlighting its remarkable ability to rapidly alleviate severe pruritus (often ...

Starjemza (ustekinumab-hmny) was approved by the FDA this week as a biosimilar to Stelara. 2 A pair of clinical trials ...